Tupperware's stock soars more than 23%, on pace for largest gain since August
By James Rogers
Tupperware issued a going-concern warning in August
Tupperware Brands Corp.'s stock rose 23.5% Tuesday, putting it on pace for its largest single-day percentage gain since Aug. 4, when it gained 35.3%.
The company's stock has attracted plenty of attention in recent months, despite Tupperware's (TUP) woes.
Related: How 'left-for-dead' Tupperware became a buzzy trading play
Back in April, Tupperware issued a going-concern warning, essentially cautioning that it could go bust. Nonetheless, shares of the beleaguered maker of iconic food-storage containers enjoyed a record 434% gain in July on no apparent news.
The company's stock has climbed 101.3% in the last three months, compared with the S&P 500's SPX decline of 1.7%.
Related: Tupperware and Yellow have skyrocketed, but don't confuse them with meme stocks
In a filing Tuesday, Tupperware said that former Herbalife Ltd. (HLF) CEO Richard Goudis plans to resign as Tupperware's executive vice chair and director. "Mr. Goudis' decision to resign from the Company was not due to any disagreement with the Company, its management or the Board of Directors on any matter relating to the Company's operations, policies or practices," Tupperware said in the filing.
Goudis's resignation will be effective following the filing of Tupperware's annual report, which is expected by mid-October. He joined Tupperware in March 2020 after 14 years at Herbalife, where he served as CEO, chief operating officer and chief financial officer.
-James Rogers
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-10-23 1353ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth